BRFSS Asthma Call-back Survey Prevalence TABLE 9

TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 Click here to skip to citation 1 with current2 Click here to skip to citation 2 or active3 Click here to skip to citation 3 asthma status by state/territory - BRFSS Asthma Call-back Survey, United States, 2010
State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 302 27.8 3.8 (20.4 - 35.2) 317 25.3 3.5 (18.4 - 32.2)
Arizona 273 31.7 6.2 (19.5 - 43.9) 283 31.0 6.1 (19.0 - 43.0)
California 502 36.3 2.9 (30.6 - 42.0) 545 33.6 2.8 (28.1 - 39.1)
Connecticut 250 37.0 4.9 (27.4 - 46.6) 283 34.5 4.4 (25.9 - 43.1)
District of Columbia 134 43.5 5.9 (31.9 - 55.1) 151 39.8 5.5 (29.0 - 50.6)
Florida 414 36.3 4.6 (27.3 - 45.3) 449 33.5 4.4 (24.9 - 42.1)
Georgia 171 27.4 4.5 (18.6 - 36.2) 176 29.0 4.6 (20.0 - 38.0)
Hawaii 271 41.4 4.9 (31.8 - 51.0) 287 42.8 4.7 (33.6 - 52.0)
Illinois 166 36.1 5.2 (25.9 - 46.3) 173 34.9 5.0 (25.1 - 44.7)
Indiana 482 32.3 3.1 (26.2 - 38.4) 508 32.7 3.0 (26.8 - 38.6)
Iowa 261 31.0 3.7 (23.7 - 38.3) 270 29.5 3.6 (22.4 - 36.6)
Kansas 426 37.0 3.8 (29.6 - 44.4) 442 36.0 3.7 (28.7 - 43.3)
Louisiana 187 20.1 4.0 (12.3 - 27.9) 203 22.2 4.0 (14.4 - 30.0)
Maine 466 34.5 3.0 (28.6 - 40.4) 486 34.4 3.0 (28.5 - 40.3)
Maryland 256 28.3 4.4 (19.7 - 36.9) 284 27.5 4.1 (19.5 - 35.5)
Massachusetts 220 32.1 5.0 (22.3 - 41.9) 231 33.6 5.0 (23.8 - 43.4)
Michigan 540 36.1 3.0 (30.2 - 42.0) 573 35.0 2.9 (29.3 - 40.7)
Mississippi 330 25.3 3.2 (19.0 - 31.6) 339 24.3 3.1 (18.2 - 30.4)
Missouri 265 43.8 5.2 (33.6 - 54.0) 280 40.0 4.8 (30.6 - 49.4)
Montana 326 27.9 3.8 (20.5 - 35.3) 339 26.4 3.6 (19.3 - 33.5)
Nebraska 607 31.2 3.9 (23.6 - 38.8) 633 32.8 3.5 (25.9 - 39.7)
Nevada 143 27.2 5.1 (17.2 - 37.2) 168 23.6 4.5 (14.8 - 32.4)
New Hampshire 283 35.8 4.4 (27.2 - 44.4) 306 35.2 4.3 (26.8 - 43.6)
New Jersey 346 30.9 3.9 (23.3 - 38.5) 377 28.7 3.5 (21.8 - 35.6)
New Mexico 333 37.0 4.7 (27.8 - 46.2) 351 36.8 4.5 (28.0 - 45.6)
New York 133 43.2 5.8 (31.8 - 54.6) 145 43.1 5.6 (32.1 - 54.1)
North Dakota 178 38.5 6.1 (26.5 - 50.5) 185 38.5 5.9 (26.9 - 50.1)
Ohio 357 31.9 4.2 (23.7 - 40.1) 382 30.2 4.0 (22.4 - 38.0)
Oklahoma 343 35.2 4.1 (27.2 - 43.2) 365 33.5 3.9 (25.9 - 41.1)
Oregon 208 36.5 5.3 (26.1 - 46.9) 234 32.7 4.7 (23.5 - 41.9)
Pennsylvania 412 38.4 3.4 (31.7 - 45.1) 437 38.7 3.3 (32.2 - 45.2)
Rhode Island 326 34.9 3.8 (27.5 - 42.3) 349 34.1 3.7 (26.8 - 41.4)
Texas 651 37.5 4.7 (28.3 - 46.7) 721 35.1 4.5 (26.3 - 43.9)
Utah 438 32.2 4.3 (23.8 - 40.6) 460 34.1 4.0 (26.3 - 41.9)
Vermont 403 36.9 3.4 (30.2 - 43.6) 435 34.2 3.2 (27.9 - 40.5)
Washington 676 32.1 3.0 (26.2 - 38.0) 706 32.4 2.8 (26.9 - 37.9)
West Virginia 205 29.8 4.1 (21.8 - 37.8) 203 30.8 4.2 (22.6 - 39.0)
Wisconsin 221 44.8 6.1 (32.8 - 56.8) 243 40.8 5.4 (30.2 - 51.4)
Puerto Rico 118 N/A N/A (N/A - N/A) 159 24.9 7.3 (10.6 - 39.2)
39 state total 12,623 35.4 1.0 (33.4 - 37.4) 13,478 34.0 1.0 (32.0 - 36.0)
Median   35.1       33.6    
Range   20.1-44.8       22.2-43.1    

1 Aged ≥ 18 years

2 "Yes" response to "Do you still have asthma?"

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Sample size excludes "DK/Refused"

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30